Annual Total Debt
$2.15 M
+$473.00 K+28.14%
December 31, 2023
Summary
- As of March 10, 2025, TOVX annual total debt is $2.15 million, with the most recent change of +$473.00 thousand (+28.14%) on December 31, 2023.
- During the last 3 years, TOVX annual total debt has risen by +$1.68 million (+355.39%).
- TOVX annual total debt is now -81.27% below its all-time high of $11.50 million, reached on December 1, 2002.
Performance
TOVX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$1.74 M
-$91.00 K-4.97%
September 30, 2024
Summary
- As of March 10, 2025, TOVX quarterly total debt is $1.74 million, with the most recent change of -$91.00 thousand (-4.97%) on September 30, 2024.
- Over the past year, TOVX quarterly total debt has stayed the same.
- TOVX quarterly total debt is now -85.48% below its all-time high of $11.97 million, reached on September 1, 2002.
Performance
TOVX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
TOVX Total Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +28.1% | 0.0% |
3 y3 years | +355.4% | 0.0% |
5 y5 years | +100.0% | 0.0% |
TOVX Total Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +41.1% | -29.4% | +5.1% |
5 y | 5-year | at high | +355.4% | -29.4% | +329.4% |
alltime | all time | -81.3% | -100.0% | -85.5% | -100.0% |
Theriva Biologics Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $1.74 M(-5.0%) |
Jun 2024 | - | $1.83 M(-9.3%) |
Mar 2024 | - | $2.02 M(-6.3%) |
Dec 2023 | $2.15 M(+28.1%) | $2.15 M(-3.1%) |
Sep 2023 | - | $2.22 M(-5.7%) |
Jun 2023 | - | $2.36 M(-4.4%) |
Mar 2023 | - | $2.46 M(+46.6%) |
Dec 2022 | $1.68 M(+10.1%) | $1.68 M(+1.6%) |
Sep 2022 | - | $1.66 M(-2.5%) |
Jun 2022 | - | $1.70 M(-4.3%) |
Mar 2022 | - | $1.77 M(+16.2%) |
Dec 2021 | $1.53 M(+222.8%) | - |
Dec 2021 | - | $1.53 M(-3.1%) |
Sep 2021 | - | $1.58 M(-2.8%) |
Jun 2021 | - | $1.62 M(+300.5%) |
Mar 2021 | - | $405.00 K(-14.4%) |
Dec 2020 | $473.00 K(-34.5%) | $473.00 K(-12.2%) |
Sep 2020 | - | $539.00 K(-10.5%) |
Jun 2020 | - | $602.00 K(-9.2%) |
Mar 2020 | - | $663.00 K(-8.2%) |
Dec 2019 | $722.00 K(>+9900.0%) | $722.00 K(-7.4%) |
Sep 2019 | - | $780.00 K(-6.5%) |
Jun 2019 | - | $834.00 K(-6.0%) |
Mar 2019 | - | $887.00 K(>+9900.0%) |
Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2018 | - | $0.00(0.0%) |
Jun 2018 | - | $0.00(0.0%) |
Mar 2018 | - | $0.00(0.0%) |
Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2017 | - | $0.00(0.0%) |
Jun 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2016 | - | $0.00(0.0%) |
Jun 2016 | - | $0.00(0.0%) |
Mar 2016 | - | $0.00(0.0%) |
Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2015 | - | $0.00(0.0%) |
Jun 2015 | - | $0.00(0.0%) |
Mar 2015 | - | $0.00(0.0%) |
Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2014 | - | $0.00(0.0%) |
Jun 2014 | - | $0.00(0.0%) |
Mar 2014 | - | $0.00(0.0%) |
Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2013 | - | $0.00(0.0%) |
Jun 2013 | - | $0.00(0.0%) |
Mar 2013 | - | $0.00(0.0%) |
Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2012 | - | $0.00(0.0%) |
Jun 2012 | - | $0.00(0.0%) |
Mar 2012 | - | $0.00(0.0%) |
Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2011 | - | $0.00(0.0%) |
Jun 2011 | - | $0.00(0.0%) |
Mar 2011 | - | $0.00(0.0%) |
Dec 2010 | $0.00 | $0.00(-100.0%) |
Sep 2010 | - | $18.90 K(-11.3%) |
Jun 2010 | - | $21.30 K(-18.7%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $26.20 K(-12.1%) |
Dec 2009 | $29.80 K(>+9900.0%) | $29.80 K(>+9900.0%) |
Sep 2009 | - | $0.00(0.0%) |
Jun 2009 | - | $0.00(0.0%) |
Mar 2009 | - | $0.00(0.0%) |
Dec 2008 | $0.00(-100.0%) | $0.00(0.0%) |
Sep 2008 | - | $0.00(0.0%) |
Jun 2008 | - | $0.00(0.0%) |
Mar 2008 | - | $0.00(-100.0%) |
Dec 2007 | $900.00 K(>+9900.0%) | $900.00 K(-10.0%) |
Sep 2007 | - | $1.00 M(+81.8%) |
Jun 2007 | - | $550.00 K(-8.3%) |
Mar 2007 | - | $600.00 K(>+9900.0%) |
Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2006 | - | $0.00(0.0%) |
Jun 2006 | - | $0.00(0.0%) |
Mar 2006 | - | $0.00(-100.0%) |
Dec 2005 | $0.00(-100.0%) | - |
Mar 2003 | - | $11.50 M(0.0%) |
Dec 2002 | $11.50 M(+27.8%) | $11.50 M(-4.0%) |
Sep 2002 | - | $11.97 M(+4.1%) |
Jun 2002 | - | $11.50 M(+15.0%) |
Mar 2002 | - | $10.00 M(+11.1%) |
Dec 2001 | $9.00 M(+350.0%) | $9.00 M(+80.0%) |
Sep 2001 | - | $5.00 M(+150.0%) |
Jun 2001 | - | $2.00 M(0.0%) |
Mar 2001 | - | $2.00 M(0.0%) |
Dec 2000 | $2.00 M(0.0%) | $2.00 M(0.0%) |
Sep 2000 | - | $2.00 M(0.0%) |
Jun 2000 | - | $2.00 M(0.0%) |
Mar 2000 | - | $2.00 M(0.0%) |
Dec 1999 | $2.00 M(+81.8%) | $2.00 M(+233.3%) |
Sep 1999 | - | $600.00 K(-60.0%) |
Jun 1999 | - | $1.50 M(-6.3%) |
Mar 1999 | - | $1.60 M(+45.5%) |
Dec 1998 | $1.10 M(-31.3%) | $1.10 M(+120.0%) |
Sep 1998 | - | $500.00 K(>+9900.0%) |
Jun 1998 | - | $0.00(-100.0%) |
Mar 1998 | - | $900.00 K(-43.8%) |
Dec 1997 | $1.60 M(>+9900.0%) | $1.60 M(-11.1%) |
Sep 1997 | - | $1.80 M(>+9900.0%) |
Jun 1997 | - | $0.00(0.0%) |
Mar 1997 | - | $0.00(0.0%) |
Dec 1996 | $0.00(-100.0%) | $0.00(0.0%) |
Sep 1996 | - | $0.00(0.0%) |
Jun 1996 | - | $0.00(0.0%) |
Mar 1996 | - | $0.00(-100.0%) |
Dec 1995 | $200.00 K(>+9900.0%) | $200.00 K(>+9900.0%) |
Sep 1995 | - | $0.00(0.0%) |
Jun 1995 | - | $0.00(0.0%) |
Mar 1995 | - | $0.00(0.0%) |
Dec 1994 | $0.00(0.0%) | $0.00(0.0%) |
Sep 1994 | - | $0.00(0.0%) |
Jun 1994 | - | $0.00(0.0%) |
Mar 1994 | - | $0.00(0.0%) |
Dec 1993 | $0.00 | $0.00(0.0%) |
Sep 1993 | - | $0.00(-100.0%) |
Jun 1993 | - | $100.00 K(-87.5%) |
Mar 1993 | - | $800.00 K |
FAQ
- What is Theriva Biologics annual total debt?
- What is the all time high annual total debt for Theriva Biologics?
- What is Theriva Biologics annual total debt year-on-year change?
- What is Theriva Biologics quarterly total debt?
- What is the all time high quarterly total debt for Theriva Biologics?
- What is Theriva Biologics quarterly total debt year-on-year change?
What is Theriva Biologics annual total debt?
The current annual total debt of TOVX is $2.15 M
What is the all time high annual total debt for Theriva Biologics?
Theriva Biologics all-time high annual total debt is $11.50 M
What is Theriva Biologics annual total debt year-on-year change?
Over the past year, TOVX annual total debt has changed by +$473.00 K (+28.14%)
What is Theriva Biologics quarterly total debt?
The current quarterly total debt of TOVX is $1.74 M
What is the all time high quarterly total debt for Theriva Biologics?
Theriva Biologics all-time high quarterly total debt is $11.97 M
What is Theriva Biologics quarterly total debt year-on-year change?
Over the past year, TOVX quarterly total debt has changed by $0.00 (0.00%)